Core Viewpoint - The company maintains a "buy" rating due to the continuous improvement in paid subscription rates for imaging products, the potential for margin enhancement, and the strategic focus on global expansion and productivity scenarios [1][2][3] Revenue Summary - In H1 2025, the company's revenue reached 1.82 billion, a year-over-year increase of 12.3%, which was below Bloomberg's consensus estimate of 24.8% due to a strategic reduction in low-margin cosmetics supply chain business [2] - Imaging and design product revenue grew by 45.2% year-over-year, with a paid subscription penetration rate of 5.5%, an increase of 1.3 percentage points year-over-year [2] - Monthly Active Users (MAU) reached 280 million, up 8.5% year-over-year, with domestic MAU growing by 5.2% and overseas MAU by 15.3% [2] Profit Summary - Adjusted net profit for H1 2025 was 470 million, a year-over-year increase of 71.3%, exceeding Bloomberg's consensus estimate of 50.9% [2] - Gross margin improved by 8.6 percentage points year-over-year, while R&D expense ratio decreased by 1.4 percentage points, benefiting from improved revenue structure and reduced training costs [2] Strategic Focus - The company is concentrating on AI deepening, with a large C-end user base and potential growth in B-end productivity scenarios and global expansion [3] - The strategy includes focusing on high-margin imaging business while reducing involvement in the beauty industry, with expectations of operational leverage release as training costs decline [3]
美图公司(01357.HK)：聚焦核心影像业务 AI驱动付费率持续提升